Eterna Therapeutics
ERNA
7 hedge funds and large institutions have $1.13M invested in Eterna Therapeutics in 2020 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 0 reducing their positions, and 2 closing their positions.
22% less funds holding
Funds holding: 9 → 7 (-2)
33% less capital invested
Capital invested by funds: $1.69M → $1.13M (-$559K)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$30.4K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CA
Callahan Advisors
Houston,
Texas
|
-$41K |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$38K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
NSIM
1
North Star Investment Management
Chicago,
Illinois
| $477K | – | – | – |
|
|
BA
2
Bard Associates
Chicago,
Illinois
| $404K | – | – | – |
|
3
Renaissance Technologies
New York
| $94K | – | – | – |
|
|
4
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| $50K | +$30.4K | +1 | +100% |
|
5
PNC Financial Services Group
Pittsburgh,
Pennsylvania
| $46K | – | – | – |
|
6
Geode Capital Management
Boston,
Massachusetts
| $32K | – | – | – |
|
7
Vanguard Group
Malvern,
Pennsylvania
| $25K | – | – | – |
|
8
BlackRock
New York
| $5K | – | – | – |
|
9
UBS Group
Zurich,
Switzerland
| $1K | – | – | – |
|
|
CA
10
Callahan Advisors
Houston,
Texas
| – | -$41K | -1 | Closed |
|
|
11
Citadel Advisors
Miami,
Florida
| – | -$38K | -1 | Closed |
|
ERNA Hedge Fund Activity: Q1 2020 in Review
7 of the 4,538 institutional investors tracked by Wall St. Rank reported a position in Eterna Therapeutics (ERNA) for Q1 2020, worth a combined $1.13M — down 33% from $1.69M a quarter earlier.
Sellers outnumbered buyers: 2 funds closed out of ERNA and 0 opened new positions — a net loss of 2 holders — while 0 trimmed existing stakes and 1 added.
The largest buyer was Susquehanna International Group, adding an estimated $30.4K. The largest seller was Callahan Advisors, exiting entirely with an estimated $41K sold.
- 7 institutional investors held Eterna Therapeutics (ERNA) as of Q1 2020, down from 9 in Q4 2019.
- Funds reported $1.13M of Eterna Therapeutics stock for Q1 2020, down 33% quarter-over-quarter.
- 0 funds opened new Eterna Therapeutics positions in Q1 2020 and 2 closed out, a net change of -2 holders.
- The largest Eterna Therapeutics buyer in Q1 2020 was Susquehanna International Group, an estimated $30.4K added.
- The largest Eterna Therapeutics seller in Q1 2020 was Callahan Advisors, an estimated $41K sold.
Based on aggregated 13F filings for Q1 2020.